Teva withdraws proposal to acquire Mylan
MLex Summary: Teva Pharmaceutical Industries says it has withdrawn its proposal to acquire Mylan. The decision to end the unsolicited bid came after Teva agreed to buy Allergan’s generic drugs business for...To view the full article, register now.
Already a subscriber? Click here to view full article